Category

Recently, NextSource Pharma’s pricing of Gleostine® (lomustine) was questioned by national media for a series of price increases over the past three years. The subject of drug pricing is an important one. It is more complex than many realize. In general, pricing is determined based on a number of factors including product development costs, regulatory […]

Gleostine® is an FDA-approved chemotherapeutic drug indicated for use in patients with brain tumors, primary and metastatic, following appropriate surgical and/or radiotherapeutics procedures as well with Hodgkin’s lymphoma in combination with other chemotherapies, following disease progression with initial chemotherapy. Product pricing is established based on several important factors including product development costs, regulatory agency fees, […]